Претрага
Резултати
Crohn's Disease Behavior as a Risk Factor for Loss of Maintenance of Remission in Patients Treated With Certolizumab Pegol: Results From the PRECiSE 3 Study [2014]
Rubin, David T; Randall, Charles; Coarse, Jason; Kosutic, Gordana; Spearman, Marshall; Ambarkhane, Sumeet; Jojic, Njegica ZOzanimod in Patients with Moderate-to-Severe Ulcerative Colitis: Long-Term Safety and Efficacy from the Phase 2 TOUCHSTONE Study 4-Year Open-Label Extension [2020]
Danese, Silvio; Feagan, Brian G; Hanauer, Stephen B; Jovanovic, Igor; Ghosh, Subrata; Petersen, AnnKatrin; Hua, Steven; Lee, Hwan Ji; Charles, Lorna; Chitkara, Denesh;
Sandborn, William J; D'Haens, Geert;
Multicentric Reticulohistiocytosis: A Unique Case of Chronic Colitis [2016]
Kurtcehajic, Admir; Zerem, Enver; Boričić, Ivan
; Hujdurovic, Ahmed; Zerem, Omar
Assessment of Fecal Markers and Clinical Outcomes in Patients With Moderately to Severely Active Ulcerative Colitis: Results from PURSUIT-SC Induction [2014]
Sandborn, William J; Feagan, Brian G; Marano, Colleen W; Strauss, Richard S; Johanns, Jewel; Zhang, Hongyan; Colombel, Jean-Frederic; Reinisch, Walter; Gibson, Peter R; Collins, Judith;
Tarabar, Dino K; Hebzda, Zbigniew; Rutgeerts, Paul;
Long-Term Mucosal Healing, Clinical Response and Clinical Remission in Patients With Ulcerative Colitis Treated With the Anti-MAdCAM-1 Antibody Ontamalimab: Results From the Open-Label Extension Study TURANDOT II [2019]
Danese, Silvio; ...; Tarabar, Dino K; ...; (broj, koautora 17)Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study [2020]
Sandborn, William J; D'Haens, Geert; Wolf, Doug; Hanauer, Stephen B; Jovanovic, Igor; Ghosh, Subrata; Petersen, Ann Katrin; Hua, Steven; Lee, Hwan Ji; Charles, Lorna;
Usiskin, Keith; Danese, Silvio; Feagan, Brian G;
Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg) [2025]
Casas, Deza Diego; ...; Milivojevic, Vladimir ; ...; (broj, koautora 50)
Increased Response and Remission Rates in Short-Duration Crohn's Disease With Subcutaneous Certolizumab Pegol: An Analysis of PRECiSE 2 Randomized Maintenance Trial Data [2010]
Schreiber, Stefan; Colombel, Jean-Frédéric; Bloomfield, Ralph; Nikolaus, Susanna; Schölmerich, Jürgen; Panés, Julian; Sandborn, William JAutologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis [2008]
Pai, Madhava; Milićević, Miroslav; Glibetić, Marija
Long-Term Safety, Efficacy and Pharmacokinetics of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 (MAdCAM-1) Monoclonal Antibody SHP647 in Crohn's Disease: The OPERA II Study [2018]
D'Haens, Geert R; ...; Tarabar, Dino K; ...; (broj, koautora 16)Филтери
По типу
- 26